Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02634788 · ClinicalTrials.gov registry record · Phase 3
Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3 study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 322
- Enrollment target
NCT02634788 is a Phase 3 study that has completed, run by INSYS Therapeutics. The registered enrollment target is 322 participants.
The verdict
NCT02634788, a Phase 3 study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 322 participants
- Enrollment target
Study Summary
The primary objective of this trial is to evaluate analgesic efficacy of Buprenorphine Sublingual (under the tongue) Spray compared with placebo in participants with postoperative pain after bunionectomy.
Interventions
- DRUG Placebo
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2016-01-29 |
| Est. Completion | 2016-06-24 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02634788
The ClinicalTrials.gov registry entry for NCT02634788 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02634788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02634788 about?
NCT02634788 is a clinical study titled "Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain". The primary objective of this trial is to evaluate analgesic efficacy of Buprenorphine Sublingual (under the tongue) Spray compared with placebo in participants with postoperative pain after bunionectomy.
What is the current status of trial NCT02634788?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 322 participants. The study started on 2016-01-29. Estimated completion is 2016-06-24.
What interventions are being tested in trial NCT02634788?
The interventions under investigation include: Placebo (DRUG), Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT02634788?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.